RoslynBernsteinMannonMD

Nephrology • Omaha, NE

Kidney & Pancreas Transplantation

Professor, Medicine, University of Nebraska Medical Center

Join to view full profile

Dr. Mannon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mannon's full profile

Already have an account?

Office
983040 Nebraska Medical Center
Omaha, NE 68198
Phone+1 402-559-9227

Fax+1 402-559-9504

Summary

Vice Chair of Research,
Department of Medicine
Associate Chief for Research, Division of Nephrology

Education & Training

Duke University HospitalFellowship, Nephrology, 1988 - 1990
Duke University HospitalResidency, Internal Medicine, 1985 - 1988
Duke University School of MedicineClass of 1985

Certifications & Licensure

NE State Medical License 2020 - 2026
AL State Medical License 2008 - 2025
NC State Medical License 1987 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014-2020
Fellow American Society of Transplantation, 2015
President American Society of Transplantation, 2012
Fellow (ASNF) American Society of Nephrology
Join now to see all

Clinical Trials

Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation Start of enrollment: 2011 Sep 01
Terminated
Phase 2
Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation Start of enrollment: 2013 Feb 01
Terminated
Phase 2
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen Start of enrollment: 2013 Jul 01
Terminated
Phase 2

Publications & Presentations

PubMed

Combination Automated Microfluidics Measurement of Urine CCL2, CXCL9, CXCL10 and VEGF-A for Monitoring Patients with a Kidney Transplant.
Michael E Seifert, Alvin T Kho, Lea Sheward, Nancy Rodig, Sarah Goldberg
Clinical Journal of the American Society of Nephrology. 2025-03-11
Biomarkers of Rejection in Kidney Transplantation.
Scott G Westphal, Roslyn B Mannon
American Journal of Kidney Diseases. 2025-03-01
3 citations
Subthreshold rejection activity in many kidney transplants currently classified as having no rejection.
Philip F Halloran, Katelynn S Madill-Thomsen, Georg Böhmig, Jonathan Bromberg, Klemens Budde
American Journal of Transplantation. 2025-01-01

Journal Articles

Repeat Kidney Transplant Recipients with Active Rejection Have Elevated Donor‐Derived Cell‐Free DNA
Roslyn B Mannon, Jonathan S Bromberg, Shikha G Mehta, American journal of transplantation
Author Correction: Metformin Reverses Established Lung Fibrosis in a Bleomycin Model
Morgan L Locy, Roslyn B Mannon, Sunad Rangarajan, Edward Abraham, Nature
Metformin Reverses Established Lung Fibrosis in a Bleomycin Model
Sunad Rangarajan, Morgan L Locy, Edward Abraham, Roslyn B Mannon, Nature
Meeting Report of the STAR – Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ Subgroup Focus on Kidney Transplantation
Kenneth Newell, Roslyn B Mannon, American journal of transplantation
Join now to see all

Lectures

Nephrology Quiz and Questionnaire 2019
American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019

Press Mentions

Noninvasive Tests to Detect Kidney Transplant Rejection: The Search ContinuesAugust 12th, 2022
#NephMadness 2021: Introducing the Blue Ribbon PanelFebruary 18th, 2021
Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker TestFebruary 8th, 2021
Join now to see all

Grant Support

An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)OMAHA VA MEDICAL CENTER2024–2029
An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)OMAHA VA MEDICAL CENTER2024–2029
An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)OMAHA VA MEDICAL CENTER2024–2029
An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)OMAHA VA MEDICAL CENTER2024–2029
4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical CenterUNIVERSITY OF ALABAMA AT BIRMINGHAM2017–2028
4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical CenterUNIVERSITY OF ALABAMA AT BIRMINGHAM2017–2028
Chronic Allograft Nephropathy (Can):Translational Approaches To The PathogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
Kidney/Pancreas Allograft Rejection: Clinical Studies And Technology DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases2007
Chronic Allograft Nephropathy (Can):Translational ApproaNational Institute Of Diabetes And Digestive And Kidney Diseases2006
Connective Tissue GF In Chronic Allograft NephropathyNational Institute Of Diabetes And Digestive And Kidney Diseases2005
Allograft Neuropathy And Connective Tissue Growth FactorNational Institute Of Diabetes And Digestive And Kidney Diseases2004
The Role Of Connective Tissue Growth Factor In Chronic ANational Institute Of Diabetes And Digestive And Kidney Diseases2003
Regulation Of Thymocyte Apoptosis By Thromboxane A2National Institute Of Allergy And Infectious Diseases1996–2000